Microcap Ledger

Tickers · $UPXI

Upexi, Inc. $UPXI

By Microcap Ledger desk · CIK 0001775194

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Finance Services
Headquarters
Tampa, FL
Fiscal year end
June 30
Shares outstanding
82,102,474 [10-K 2026-09-17]
as of 2026-09-15

Sources: [10-K 2026-09-17]

What the company doesAI summary of filing

Upexi, Inc. is a cryptocurrency treasury company that holds and stakes Solana (SOL) tokens on its balance sheet to generate yield, with approximately 95% of its SOL treasury currently staked with validators. The company also owns and sells consumer product brands, including LuckyTail (pet care products), PRAX (energy drinks with paraxanthine), and Cure Mushrooms (functional mushroom extracts), through direct-to-consumer channels, wholesale partnerships, and third-party platforms like Amazon, with distribution handled by third-party fulfillment providers. The company generates revenue from staking rewards earned on its Solana holdings and from consumer product sales. Upexi is revenue-generating and holds approximately $165.3 million in SOL treasury value as of June 30, 2026. [10-K 2026-09-17]

Segments: Solana Treasury and Staking, LuckyTail, PRAX, Cure Mushrooms

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
FY ended Jun 2026$25.00M−$246.06M −$20.96M$5.78M[10-K 2026-09-17]
FY ended Jun 2025$15.81M−$13.68M −$8.42M$2.98M[10-K 2026-09-17]
Quarterly cash burn
−$5.24M
Cash runway Estimate
~3.3 months

Estimate: cash at the end of the period (FY ended Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-12-191,040,924[10-Q 2024-12-19]
2025-02-141,320,924[10-Q 2025-02-14]
2025-05-1437,253,373[10-Q 2025-05-16]
2025-09-2358,888,756[10-K 2025-09-24]
2025-11-1259,918,609[10-Q 2025-11-12]
2026-02-0969,760,581[10-Q 2026-02-10]
2026-05-1170,261,828[10-Q 2026-05-12]
2026-09-1582,102,474[10-K 2026-09-17]
Shelf registration
S-3 filed 2026-07-06; declared effective 2026-07-16 [S-3 2026-07-06]

Listing status

Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-31. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2026-07-318-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-07-31]
2026-06-268-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-06-26]
2024-11-228-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2024-11-22]
2024-10-238-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2024-10-23]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-07-03Salkind Genegrant100,000—[4 2026-07-20]
2026-07-03Dugan Lawrencegrant100,000—[4 2026-07-20]
2026-07-03Rudick Brian Benjamingrant400,000—[4 2026-07-20]
2026-07-03Marshall Allangrant2,000,000—[4 2026-07-20]
2026-07-03Norstrud Andrew Jamesgrant400,000—[4 2026-07-20]
2025-12-23Marshall Allanbuy50,000$1.80[4 2025-12-23]
2025-12-16Marshall Allanbuy50,000$2.07[4 2025-12-17]
2025-12-15Marshall Allanbuy100,000$2.07[4 2025-12-17]
2025-11-20Salkind Genebuy50,000$2.55[4 2025-11-21]
2025-10-01Marshall Allangrant1,600,000—[4 2025-12-17]

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.